Asklepios Kliniken

Association of prothrombin complex concentrate administration and hematoma enlargement in non-vitamin K antagonist oral anticoagulant-related intracerebral hemorrhage (2018) Gerner S, Kuramatsu J, Sembill J, Sprügel M, Endres M, Haeusler KG, Vajkoczy P, et al. Journal article Using the sleeve technique in a mouse model of aortic transplantation - An instructional video (2017) Rowinska Z, Gorressen S, Merx MW, Koeppel TA, Zernecke A, Liehn EA Journal article Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial (2017) San-Miguel JF, Hungria VTM, Yoon SS, Beksac M, Dimopoulos MA, Elghandour A, Jedrzejczak WW, et al. Journal article Depression and inflammatory arthritis are associated in both Western and Non-Western countries: Findings from the World Health Survey 2002 (2017) Apfelbacher C, Brandstetter S, Herr RM, Ehrenstein B, Loerbroks A Journal article OPEN-LABEL, MULTICENTER, DOSE-ESCALATING PHASE II CLINICAL TRIAL ON THE SAFETY AND EFFICACY OF TADEKINIG ALPHA IN ADULT ONSET STILL'S DISEASE (2017) Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Koetter I, Hachulla E, et al. Conference contribution EVALUATION OF FREQUENCY AND TYPE OF PHYSICAL THERAPY IN MORE THAN 3400 PATIENTS WITH SYSTEMIC SCLEROSIS (2017) Belz D, Moinzadeh P, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution DIFFUSING CAPACITY AND CLINICAL CHARACTERISTICS OF PATIENTS WITH SYSTEMIC SCLEROSIS - DATA FROM THE GERMAN NETWORK FOR SYSTEMIC SCLEROSIS (2017) Moinzadeh P, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, Schmalzing M, et al. Conference contribution Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease (2017) Atreya R, Kuehbacher T, Waldner M, Hirschmann S, Drvarov O, Abu Hashem R, Maaser C, et al. Conference contribution norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study (2017) Traussnigg S, Schattenberg JM, Demir M, Wiegand J, Geier A, Teuber G, Hofmann WP, et al. Conference contribution ELEVATED MULTI-BIOMARKER DISEASE ACTIVITY (MBDA) PREDICTS RELAPSES IN RA PATIENTS IN SUSTAINED REMISSION TAPERING TUMOUR NECROSIS FACTOR INHIBITOR THERAPY-RESULTS FROM THE RANDOMIZED CONTROLLED RETRO STUDY (2017) Rech J, Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, et al. Conference contribution